Adams Street Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Adams Street Partners’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$227K	Buy	+22,921	New	+$225K	0.57%	10

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Adams Street Partners's IRWD Position: Q3 2013 in Review

Adams Street Partners opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2013: 22,921 shares worth $227K. The stake represents 0.57% of the portfolio and ranks #10 among its holdings.

124 funds tracked by Wall St. Rank hold IRWD as of Q3 2013.

Adams Street Partners held 22,921 shares of Ironwood Pharmaceuticals worth $227K as of Q3 2013.
Ironwood Pharmaceuticals was a new Adams Street Partners position in Q3 2013.
Ironwood Pharmaceuticals made up 0.57% of Adams Street Partners's portfolio in Q3 2013, its #10 holding.
124 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2013.

Based on Adams Street Partners's 13F filing for Q3 2013, filed 14 Nov 2013.